THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics (NasdaqGM: RPRX) today announced financial results for the three-month and six-month periods ended June 30, 2007. Financial Results Total revenues for the three-month period ended June 30, 2007 were $442,000 as compared to $166,000 for same period in the prior year and were $759,000 for the six-month period ended June 30, 2007 as compared to $340,000 for the same period in the prior year. Revenues for the three-month and six-month periods ended June 30, 2007 consist of interest income and the increase in interest income is primarily due to an increase in marketable securities as a result of the completion of the Company’s follow-on public offering on February 5, 2007 in which the Company received approximately $33.1 million in net proceeds.
